Related Experiment Video

Updated: Jun 11, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

[Applicability of coexpression networks analysis to anticancer drug targets discovery]

A E Ivliev, V A Rudneva, M G Sergeeva

    Molekuliarnaia Biologiia
    |July 1, 2010
    PubMed

    Insights

    Coexpression network analysis effectively predicts anticancer drug targets. Hubs within the cell proliferation and mitosis module are highly correlated with existing drug targets, suggesting their potential for novel therapeutic development.

    Area of Science:

    • Molecular biology
    • Genomics
    • Bioinformatics

    Context:

    • Identifying therapeutic targets is crucial for molecular biology and cancer research.
    • Transcriptomics, specifically coexpression network analysis, has shown promise for drug target discovery.
    • Glioblastoma, a highly malignant brain tumor, presents a significant challenge for effective cancer therapy.

    Purpose:

    • To evaluate the applicability of coexpression network analysis for predicting novel anticancer drug targets.
    • To compare the network positions of known anticancer drug targets versus non-anticancer drug targets in glioblastoma.
    • To identify specific coexpression modules associated with anticancer drug target characteristics.

    Summary:

    • Analyzed Affymetrix GeneChip expression data from 93 glioblastoma samples to construct a coexpression network.
    • Identified coexpression modules linked to key cellular processes including proliferation, immune response, and mitosis.
    • Anticancer drug targets were significantly enriched (fourfold) in the module associated with cell proliferation and mitosis.

    Impact:

    • Demonstrated that network hubs within the mitotic module are strongly correlated with existing anticancer drug targets.
    • Validated the utility of coexpression network analysis for identifying potential novel anticancer drug targets.
    • Findings support the hypothesis that targeting hubs in the mitotic module could lead to new glioblastoma therapies.

    Related Concept Videos

    Protein Networks02:26

    Protein Networks

    An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
    These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
    Pharmacogenomics: Identification of New Drug Targets01:29

    Pharmacogenomics: Identification of New Drug Targets

    Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Drug Discovery: Overview01:26

    Drug Discovery: Overview

    Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
    Targets for Drug Action: Overview01:26

    Targets for Drug Action: Overview

    Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
    Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...